D-1376-2020 Class III Terminated

Recalled by Flexion Therapeutics, Inc. — Burlington, MA

FDA drug recall D-1376-2020 was initiated by Flexion Therapeutics, Inc. on May 19, 2020 and is designated Class III. Reason for recall: Temperature Abuse: Product was stored at room temperature longer than 6 weeks and was inadvertently distributed instead of discarded The recall status is terminated (terminated Nov 3, 2020). Affected quantity: 792 kits.

Recall details

Product Type
Drugs
Report Date
Jul 8, 2020
Initiation Date
May 19, 2020
Termination Date
Nov 3, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
792 kits

Product description

Zilretta (triamcinolone acetonide extended-release injectable suspension), 32mg per vial, 5mL vials, Single-dose Kits, Rx Only, Manufactured for: Flexion Therapeutics, Inc. 10 Mall Road, Suite 301, Burlington, MA 01803, NDC 70801-003-01

Reason for recall

Temperature Abuse: Product was stored at room temperature longer than 6 weeks and was inadvertently distributed instead of discarded

Distribution pattern

Nationwide within the United States only lots distributed by Besse Medical are affected.

Code information

Lot #: ZA19014, exp. date 05/2021 Only the specific lot distributed by Besse Medical are affected.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1376-2020
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1376-2020. Report a data issue: hello@regdatalab.com.